accountgeneric competition to several of its top drugs as well as a hole in sales from H1N1 or swine flu vaccines. The French drugmaker expects its $20.1... The French drugmaker expects its $20.1 billion cash takeover of U.S. biotech Genzyme, which it completed...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Sanofi Q1 tarnished by generics, H1N1 absence
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account